Key stats
About SPDR S&P Pharmaceuticals ETF
Home page
Inception date
Jun 19, 2006
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
SSgA Funds Management, Inc.
Distributor
State Street Corp. (Fund Distributor)
XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.83%
Health Technology99.83%
Bonds, Cash & Other0.17%
Mutual fund0.17%
Stock breakdown by region
North America91.66%
Europe7.34%
Asia1.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
XPH top holdings are Corcept Therapeutics Incorporated. and Elanco Animal Health, Inc., occupying 5.65% and 4.98% of the portfolio correspondingly.
XPH last dividends amounted to 0.15 USD. The quarter before, the issuer paid 0.15 USD in dividends, which shows a 0.99% decrease.
XPH assets under management is 141.28 M USD. It's risen 3.06% over the last month.
XPH fund flows account for −56.80 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, XPH pays dividends to its holders with the dividend yield of 1.66%. The last dividend (Mar 26, 2025) amounted to 0.15 USD. The dividends are paid quarterly.
XPH shares are issued by State Street Corp. under the brand SPDR. The ETF was launched on Jun 19, 2006, and its management style is Passive.
XPH expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.
XPH follows the S&P Pharmaceuticals Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
XPH invests in stocks.
XPH price has risen by 2.88% over the last month, and its yearly performance shows a −3.53% decrease. See more dynamics on XPH price chart.
NAV returns, another gauge of an ETF dynamics, showed a −10.97% decrease in three-month performance and has decreased by −1.91% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −10.97% decrease in three-month performance and has decreased by −1.91% in a year.
XPH trades at a premium (0.16%) meaning the ETF is trading at a higher price than the calculated NAV.